Skip to content

UroGen Pharma URGN Income Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$50.96M+152%$37.84M+54.0%$27.48M+9.0%$24.22M+10.8%$20.25M+7.8%
-$23.57M+46.2%-$26.36M+29.7%-$33.35M-40.9%-$49.94M-49.5%-$43.84M-35.8%
-46.3%+170pp-69.7%+83.0pp-121.3%-27.4pp-206.2%-53.3pp-216.5%-44.6pp
$50.96M+152%$37.84M+54.0%$27.48M+9.0%$24.22M+10.8%$20.25M+7.8%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are UroGen Pharma's profit margins?
Gross margin is 89.7% and operating margin is -329.7%, with a -94.8% net margin.
Where does UroGen Pharma's income statement data come from?
Every line is extracted from UroGen Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.